Back to search
Resolved Hepatitis B
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Resolved Hepatitis B trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Resolved Hepatitis B trials you may qualify forThe purpose of the study was to assess the efficacy and safety of telbivudine at a dose of 20 mg/kg up to a maximum of 600 mg q.d. in compensated pediatric HBeA…
Antiviral prophylaxis can prevent the risk of biologic agents-associated HBV reactivation in hepatitis B inactive carriers and patients with past HBV infection
Hepatitis B (HBV) reactivation and hepatitis flare induced by cytotoxic chemotherapy is common in cancer patients who have chronic HBV infection. Lymphoma patie…